Paper37300366
In Situ Enzymatic Reaction Generates Magnesium-Based Mineralized Microspheres with Superior Bioactivity for Enhanced Bone Regeneration.
Cai Z and 14 others. Adv Healthc Mater, 2023. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. In Situ Enzymatic Reaction Generates Magnesium-Based Mineralized Microspheres with Superior Bioactivity for Enhanced Bone Regeneration. Papers, record 37300366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37300366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In Situ Enzymatic Reaction Generates Magnesium-Based Mineralized Microspheres with Superior Bioactivity for Enhanced Bone Regeneration.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Osteogenesis | Major topic |
| Magnesium | Major topic |
| Microspheres | |
| Phosphatidylinositol 3-Kinases | |
| Bone Regeneration | |
| Cell Differentiation | |
| Phosphates | |
| Magnesium Compounds |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42366450 | [Mechanisms and applications of magnesium ion-regulated stem cell functions in promoting tendon-bone interface healing]. | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | 2026 | https://conductscience.org/library/papers/42366450 | PubMed |
| 42150917 | [Research progress on the role and mechanism of magnesium element and magnesium materials in tendon-bone interface healing]. | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | 2026 | https://conductscience.org/library/papers/42150917 | PubMed |
| 40824565 | The role of magnesium hydrogels in bone regeneration: a systematic review and meta-analysis. | J Mater Sci Mater Med | 2025 | https://conductscience.org/library/papers/40824565 | PubMed |
| 40727081 | Organoid-based tissue engineering for advanced tissue repair and reconstruction. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40727081 | PubMed |
| 40673129 | Beyond natural silk: Bioengineered silk fibroin for bone regeneration. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40673129 | PubMed |
| 40641988 | Research progress on the role and mechanism of magnesium-containing materials in bone repair. | Biomater Transl | 2025 | https://conductscience.org/library/papers/40641988 | PubMed |
| 40491456 | Enhancing Silk Fibroin Hydrogel Mechanical Properties through Biomimetic Mineralization by Self-Assembled Catalytic Complexes. | ACS Omega | 2025 | https://conductscience.org/library/papers/40491456 | PubMed |
| 40289425 | Controlled Magnesium Ion Delivery via Mg-Sputtered Nerve Conduit for Enhancing Peripheral Nerve Regeneration. | Adv Healthc Mater | 2025 | https://conductscience.org/library/papers/40289425 | PubMed |
| 40124334 | Versatile application of magnesium-related bone implants in the treatment of bone defects. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40124334 | PubMed |
| 39744680 | Standardization and consensus in the development and application of bone organoids. | Theranostics | 2025 | https://conductscience.org/library/papers/39744680 | PubMed |
| 39463918 | Rapid fabrication of biomimetic PLGA microsphere incorporated with natural porcine dermal aECM for bone regeneration. | Regen Biomater | 2024 | https://conductscience.org/library/papers/39463918 | PubMed |
| 39162584 | Correction to "Nanofibrous Microspheres: A Biomimetic Platform for Bone Tissue Regeneration". | ACS Appl Bio Mater | 2024 | https://conductscience.org/library/papers/39162584 | PubMed |
| 38950103 | Nanofibrous Microspheres: A Biomimetic Platform for Bone Tissue Regeneration. | ACS Appl Bio Mater | 2024 | https://conductscience.org/library/papers/38950103 | PubMed |
| 38874525 | Sensory Nerve Regulation via H3K27 Demethylation Revealed in Akermanite Composite Microspheres Repairing Maxillofacial Bone Defect. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38874525 | PubMed |
| 38390528 | Boosting cartilage repair with silk fibroin-DNA hydrogel-based cartilage organoid precursor. | Bioact Mater | 2024 | https://conductscience.org/library/papers/38390528 | PubMed |
| 37870197 | Pearl Powder Hybrid Bioactive Scaffolds from Microfluidic 3D Printing for Bone Regeneration. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37870197 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| ALPP | 250 | PubTator's text mining | https://conductscience.org/library/genes/250 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37300366
GET https://conductscience.org/api/papers/v1/37300366/authors